Long-Term Outcome of Intact Abdominal Aortic Aneurysm After Endovascular or Open Repair

医学 围手术期 危险系数 腹主动脉瘤 腔内修复术 倾向得分匹配 外科 优势比 置信区间 回顾性队列研究 动脉瘤 队列 主动脉瘤 存活率 内科学
作者
Jasmin Epple,Yuliya Svidlova,Thomas Schmitz‐Rixen,Dittmar Böckler,Neelam Lingwal,Reinhart T. Grundmann
出处
期刊:Vascular and Endovascular Surgery [SAGE Publishing]
卷期号:57 (8): 829-837 被引量:3
标识
DOI:10.1177/15385744231178130
摘要

Endovascular aortic aneurysm repair (EVAR) has been established as a standard treatment option for intact abdominal aortic aneurysm (iAAA) and gained importance due to a lower perioperative mortality than open repair (OAR). However, whether this survival advantage can be maintained or if OAR is beneficial in terms of long-term complications and reinterventions remains questionable.In this retrospective cohort study data from patients undergoing elective EVAR or OAR for iAAAs in the years 2010-2016 was analyzed. The patients were followed through 2018.In the propensity score matched cohorts the perioperative and long-term outcomes of the patients were assessed. We identified 20 683 patients undergoing elective iAAA repair (76.4% EVAR). The propensity matched cohorts included 4886 pairs of patients.The perioperative mortality was 1.9% for EVAR and 5.9% for OAR (P = <.001). The perioperative mortality was mainly influenced by patients age (Odds-Ratio (OR):1.073, confidence interval (CI):1.058-1.088, P ≤ .001) and OAR (OR:3.242, CI:2.552-4.119, P ≤ .001). The early survival benefit after endovascular repair persisted for approximately 3 years (estimated survival EVAR 82.3%, OAR 80.9%, P = .021). After that time the estimated survival curves were similar. After 9 years the estimated survival was 51.2% after EVAR as compared to 52.8% after OAR (P = .102). The operation method didn't influence long-term survival significantly (Hazard-Ratio (HR): 1.046, CI: .975-1.122, P = .211). The vascular reintervention rate was 17.4% in the EVAR cohort and 7.1% in the OAR cohort (P ≤ .001).EVAR has a significantly lower perioperative mortality than OAR, a survival benefit that lasts up to 3 years after intervention. Thereafter, no significant difference in survival was observed between EVAR and OAR. The decision between EVAR or OAR may depend on patient preference, surgeons' experience, and the institutions' ability to handle complications.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
xingchy发布了新的文献求助10
1秒前
1D发布了新的文献求助10
1秒前
vivien11发布了新的文献求助10
2秒前
某叶发布了新的文献求助20
2秒前
贼贼完成签到,获得积分10
3秒前
6秒前
yuni发布了新的文献求助30
6秒前
6秒前
刘广进发布了新的文献求助10
7秒前
任性冥王星完成签到 ,获得积分10
7秒前
木木白白完成签到 ,获得积分10
7秒前
阿可阿可完成签到,获得积分10
8秒前
9秒前
lfw关闭了lfw文献求助
10秒前
Mr_龙在天涯发布了新的文献求助100
11秒前
赵敏发布了新的文献求助10
12秒前
ren完成签到,获得积分10
12秒前
赘婿应助lm采纳,获得10
12秒前
29完成签到,获得积分10
12秒前
You完成签到,获得积分10
14秒前
逆时针应助刘广进采纳,获得10
15秒前
16秒前
流星完成签到,获得积分10
16秒前
17秒前
Skywalker完成签到,获得积分10
17秒前
英姑应助sdl采纳,获得10
18秒前
yu完成签到 ,获得积分10
19秒前
火锅完成签到,获得积分10
19秒前
jobeco发布了新的文献求助10
19秒前
19秒前
20秒前
鳗鱼铭完成签到,获得积分10
21秒前
21秒前
所所应助vivien11采纳,获得10
22秒前
沙海冬完成签到,获得积分10
22秒前
夜已深完成签到,获得积分10
22秒前
23秒前
激动的跳跳糖完成签到 ,获得积分10
24秒前
fanhuam发布了新的文献求助10
24秒前
24秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Organizational Behavior 510
Management and the Arts 510
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
Rosenblum, Global Change Biology 500
CLSI VET01S-2024 Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals (7th Ed) 500
DIPPR Project 801 - Full Version 380
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 化学工程 工程类 有机化学 物理 复合材料 生物化学 内科学 细胞生物学 基因 遗传学 免疫学 冶金 光电子学 癌症研究
热门帖子
关注 科研通微信公众号,转发送积分 7767689
求助须知:如何正确求助?哪些是违规求助? 9311208
关于积分的说明 20322344
捐赠科研通 7352659
什么是DOI,文献DOI怎么找? 3315436
关于科研通互助平台的介绍 2464719
邀请新用户注册赠送积分活动 2330065